Anti-obesity and LDL-cholesterol lowering effects of silkworm hemolymph in C57BL/6N mice fed high fat diet

고지방식이 비만 유도 mouse에서 누에체액의 항비만 및 LDL-cholesterol 저하효과

  • Nam, You Ree (Department of Food and Nutrition, Chungnam National University) ;
  • Ko, Young Eun (Department of Food and Nutrition, Chungnam National University) ;
  • Ly, Sun Yung (Department of Food and Nutrition, Chungnam National University)
  • 남유리 (충남대학교 식품영양학과) ;
  • 고영은 (충남대학교 식품영양학과) ;
  • 이선영 (충남대학교 식품영양학과)
  • Received : 2018.04.16
  • Accepted : 2018.06.04
  • Published : 2018.06.30


Purpose: Obesity, a worldwide epidemic, is associated with insulin resistance, hyperlipidemia, hypertension, cardiovascular disease, and certain cancers. Many strategies, including natural alternative anti-obesity agents, are used widely to prevent obesity. This study examined the effects of silkworm hemolymph on the weight control of C57BL/6N mice fed with a high-fat diet. Methods: The mice were divided into five groups: normal group (N), high-fat diet group (HFC), high-fat diet and silkworm hemolymph (at dose of 1 mL/kg BW (HFS-1), 5 mL/kg BW (HFS-5) and 10 mL/kg (HFS-10) for 12 weeks. Results: After 12 weeks treatment, the administration of silkworm hemolymph decreased the final body weight significantly along with a decrease in the weights of epididymal fat and total fat. The plasma LDL-cholesterol concentration was significantly lower in the HFS-1, HFS-5, and HFS-10 groups than in the HFC group. In addition, the leptin level of the HFS groups was significantly lower than those of the HFC group without a change in the plasma insulin concentration. Conclusion: These findings suggest that the silkworm hemolymph may have the potential to prevent obesity.

본 연구에서는 고지방식이로 유도한 비만 C57BL/6N 마우스 모델에서 누에체액 투여가 마우스의 체중 감소 및 혈중 지질 개선 효과를 보이는지 평가하였다. 실험동물은 정상군 (N), 고지방대조군 (HFC), 누에체액투여군 (HFS-1, HFS-5, HFS-10)으로 분리하여 12주 동안 열량비 10% 지방식이나 45% 지방식을 섭취시키고 고지방식이 급여군들의 일부에 누에체액을 체중 대비 1%, 5%, 10% 경구투여 하였다. 그 결과 체중과 부고환지방 및 총지방의 무게가 유의하게 감소하였으며 혈장 LDL-cholesterol 농도가 고지방대조군 (HFC)군에 비하여 HFS-1, HFS-5, HFS-10군에서 유의하게 감소하였다. 혈중 ALT와 AST의 활성은 고지방대조군에 비하여 HFS-5, HFS-10 군에서 유의하게 저하되었고 누에체액을 투여한 모든 군에서 HFC군과 비교하여 혈장 leptin 수준이 유의하게 감소하였다. 비록 누에체액의 유효성분을 동정하고 그 특성을 규명하기 위해서는 더 많은 연구를 필요로 하지만 본 연구 결과는 누에체액이 비만을 예방할 수 있는 잠재적인 천연소재로서 가능성을 보여준다.



  1. Woods SC, Seeley RJ, Porte D Jr, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science 1998; 280(5368): 1378-1383.
  2. Weiser M, Frishman WH, Michaelson MD, Abdeen MA. The pharmacologic approach to the treatment of obesity. J Clin Pharmacol 1997; 37(6): 453-473.
  3. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988; 37(9): 1163-1167.
  4. Antipatis VJ, Gill TP. Obesity as a global problem. In: Bjorntorp P, editor. International Textbook of Obesity. Chichester: John Wiley & Sons, Ltd.; 2001. p.3-22.
  5. Asano N, Oseki K, Tomioka E, Kizu H, Matsui K. N-containing sugars from Morus alba and their glycosidase inhibitory activities. Carbohydr Res 1994; 259(2): 243-255.
  6. Kimura T, Nakagawa K, Kubota H, Kojima Y, Goto Y, Yamagishi K, Oita S, Oikawa S, Miyazawa T. Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem 2007; 55(14): 5869-5874.
  7. Thaipitakwong T, Numhom S, Aramwit P. Mulberry leaves and their potential effects against cardiometabolic risks: a review of chemical compositions, biological properties and clinical efficacy. Pharm Biol 2018; 56(1): 109-118.
  8. Miyahara C, Miyazawa M, Satoh S, Sakai A, Mizusaki S. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J Nutr Sci Vitaminol (Tokyo) 2004; 50(3): 161-164.
  9. Kim GN, Kwon YI, Jang HD. Mulberry leaf extract reduces postprandial hyperglycemia with few side effects by inhibiting ${\alpha}-glucosidase$ in normal rats. J Med Food 2011; 14(7-8): 712-717.
  10. Tsuduki T, Kikuchi I, Kimura T, Nakagawa K, Miyazawa T. Intake of mulberry 1-deoxynojirimycin prevents diet-induced obesity through increases in adiponectin in mice. Food Chem 2013; 139(1-4): 16-23.
  11. Ryu KS, Lee HS, Chung SH, Kang PD. An activity of lowering blood-glucose levels according to preparative conditions of silkworm powder. J Seric Entomol Sci 1997; 39(1): 79-85.
  12. Han J, Inoue S, Isoda H. Effects of silkworm powder on glucose absorption by human intestinal epithelial cell line Caco-2. J Nat Med 2007; 61(4): 387-390.
  13. Jung EY, Lee HS, Lee HJ, Kim JM, Lee KW, Suh HJ. Feeding silk protein hydrolysates to C57BL/KsJ-db/db mice improves blood glucose and lipid profiles. Nutr Res 2010; 30(11): 783-790.
  14. Okazaki Y, Kakehi S, Xu Y, Tsujimoto K, Sasaki M, Ogawa H, Kato N. Consumption of sericin reduces serum lipids, ameliorates glucose tolerance and elevates serum adiponectin in rats fed a high-fat diet. Biosci Biotechnol Biochem 2010; 74(8): 1534-1538.
  15. Xue R, Wang Y, Cao G, Pan Z, Zheng X, Zhou W, Gong C. Lowering the blood glucose of diabetes mellitus mice by oral administration with transgenic human insulin-like growth factor I silkworms. J Agric Food Chem 2012; 60(26): 6559- 6564.
  16. Chan EW, Lye PY, Wong SK. Phytochemistry, pharmacology, and clinical trials of Morus alba. Chin J Nat Med 2016; 14(1): 17-30.
  17. Rhee WJ, Park TH. Silkworm hemolymph inhibits baculovirus- induced insect cell apoptosis. Biochem Biophys Res Commun 2000; 271(1): 186-190.
  18. Choi SS, Rhee WJ, Park TH. Inhibition of human cell apoptosis by silkworm hemolymph. Biotechnol Prog 2002; 18(4): 874-878.
  19. Choi SS, Rhee WJ, Kim EJ, Park TH. Enhancement of recombinant protein production in Chinese hamster ovary cells through anti-apoptosis engineering using 30Kc6 gene. Biotechnol Bioeng 2006; 95(3): 459-467.
  20. Yu W, Ying H, Tong F, Zhang C, Quan Y, Zhang Y. Protective effect of the silkworm protein 30Kc6 on human vascular endothelial cells damaged by oxidized low density lipoprotein (Ox-LDL). PLoS One 2013; 8(6): e68746.
  21. Koo TY, Park JH, Park HH, Park TH. Beneficial effect of 30Kc6 gene expression on production of recombinant interferon-b in serum-free suspension culture of CHO cells. Process Biochem 2009; 44(2): 146-153.
  22. Thupari JN, Kim EK, Moran TH, Ronnett GV, Kuhajda FP. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass. Am J Physiol Endocrinol Metab 2004; 287(1): E97-E104.
  23. Yun SN, Moon SJ, Ko SK, Im BO, Chung SH. Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Arch Pharm Res 2004; 27(7): 790-796.
  24. Miller WC, Lindeman AK, Wallace J, Niederpruem M. Diet composition, energy intake, and exercise in relation to body fat in men and women. Am J Clin Nutr 1990; 52(3): 426-430.
  25. Morton GJ, Gelling RW, Niswender KD, Morrison CD, Rhodes CJ, Schwartz MW. Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab 2005; 2(6): 411-420.
  26. Sullivan PW, Ghushchyan VH, Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res 2008; 17(8): 1063-1071.
  27. Yatsunami K, Ichida M, Onodera S. The relationship between 1-deoxynojirimycin content and alpha-glucosidase inhibitory activity in leaves of 276 mulberry cultivars (Morus spp.) in Kyoto, Japan. J Nat Med 2008; 62(1): 63-66.
  28. Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab 2008; 34(4 Pt 1): 317-327.
  29. Brennan AM, Mantzoros CS. Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications. Nat Clin Pract Endocrinol Metab 2006; 2(6): 318-327.
  30. Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord 2000; 24(5): 639-646.
  31. Scarpace PJ, Zhang Y. Leptin resistance: a prediposing factor for diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2009; 296(3): R493-R500.
  32. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1(11): 1155-1161.
  33. Choi SS, Rhee WJ, Park TH. Beneficial effect of silkworm hemolymph on a CHO cell system: Inhibition of apoptosis and increase of EPO production. Biotechnol Bioeng 2005; 91(7): 793-800.

Cited by

  1. Storage characteristics of two‐spotted cricket ( Gryllus bimaculatus De Geer) powder according to drying method and storage temperature vol.50, pp.11, 2020,